General Bacteriology 1 and 2. List of samples and the microbes linked to the corresponding photo replies since

Similar documents
General Bacteriology 1 (5080) and 2 (5081). List of microbes included in the specimens linked to the corresponding photo replies since

SUPPLEMENTARY MATERIAL

National Surveillance of Nosocomial Septicemia (Hospital-wide)

Supplemental Digital Content

Received 1 March 2011/Returned for modification 19 April 2011/Accepted 20 May 2011

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

Consultation on the Revision of Carbapenem Breakpoints

Labquality External Quality Assessment Programmes General Bacteriology 1 3/2014

Microsan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC #

INTRA-ABDOMINAL INFECTIONS - II

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)

Labquality External Quality Assessment Programmes General Bacteriology 1 3/2013

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

Brief Communication Clinical Microbiology

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology

M O L E C U L A R G E N E T I C S

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Comparative study of MALDI-TOF MS and VITEK 2 in bacteria identification

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

Optimizing MALDI-TOF Use. Clinical Impact Laboratory Impact

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

Yes No Unknown. In hospital Out of hospital Unknown. Blood Pump Drive Unit Failure External Control System Failure. Yes No Unknown

This material is supported in part by unrestricted educational grants from: Abbott, Bayer HealthCare, Merck Frosst, Roche Diagnostics, and Wyeth Inc.

Labquality External Quality Assessment Programmes General Bacteriology 1 2/2013

Streptococci facultative anaerobe

INFECTIOUS DISEASE. Page 2

IMIPENEM CILASTATIN SODIUM

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

VITEK MS Implementation of Mass Spectrometry

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

Labquality External Quality Assesment Programmes General Bacteriology 1 1/2010

Sep Oct Nov Dec Total

Primaxin IV Injection

MINISTRY OF HEALTH OF THE REPUBLIC OF BELARUS. Patient Information Leaflet

Surveillance of Healthcare Associated Infections in Scottish Intensive Care Units

Overview of Tigecycline and Its Role in the Era of Antibiotic Resistance

M E D I C A L L A B O R A T O R Y

Efficacy Data. Disinfectant Cleaner & Odor Counteractant EPA REG. #

In the absence of underlying edema or other skin abnormalities, erysipelas

MERREM IV. meropenem PRODUCT INFORMATION COOH CH 3

Class 15. Infections of the Central Nervous System

Utility of Gram stain in the clinical management of suspected ventilator-associated pneumonia Secondary analysis of a multicenter randomized trial

FAROBACT 200 Tablets (Faropenem)

M E D I C A L L A B O R A T O R Y

On-demand diagnosis of TB and rifampinresistance using the Xpert MTB/RIF assay: the present and the future.

Randomized Prospective Study Comparing Moxalactam and Cefoxitin with or without Tobramycin for the Treatment of Serious Surgical Infections

Bio Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease

Clinical and Microbiological Evaluation of Osteomyelitis

MALDI-TOF mass spectrometry for direct bacterial identification

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

1430 West McCoy Lane Santa Maria, CA p:

IMMUVIEW S. PNEUMONIAE ANTIGEN TEST. Lateral flow test for qualitative detection of S. pneumoniae in urine and cerebrospinal fluid.

ISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis

Osteomyelitis and septic arthritis. Osteomyelitida. Cierny- Mader (1) Bone anatomy. Cierny- Mader (2) Pathogenesis (1)

Summary of Product Characteristics

Summary of Product Characteristics

Cardiovascular Diseases. Dr. Hala Al- Daghistani

Client Services Manual

Bacteriologic Findings Associated with Chronic Bacterial Maxillary Sinusitis in Adults

Vancomycin Rationale for the EUCAST clinical breakpoints, version June 2010

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE

KOMAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (KUST) Medical Bacteriology Syllabus (Theory) Spring 2016

S. Q. van Veen,* E. C. J. Claas, and Ed J. Kuijper. Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands

ID of Most Common Bacterial Pathogens. CLS 417- Clinical Practice in Microbiology Miss Zeina Alkudmani

Wound Microbiology and Associated Approaches to Wound Management

VOLOXAL. Composition each tablet contains levofloxacin 500 & 750 mg

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory AUGMENTIN 625 / 1000 DUO

Superbugs in Dental Practice: A Narrative Review

Cefuroxime sodium equivalent to Cefuroxime 250 mg, 750 mg and 1.5 g Powder for Injection

AXITAB-CV TAB. COMPOSITION :

Discrepancies in the recovery of bacteria from multiple sinuses in acute and chronic sinusitis

Cefuroxime (as sodium)

ZOSUL Injection (Cefoperazone Sodium + Sulbactam Sodium) Cefoperazone Sodium Plus Sulbactam Sodium Injection Zosul

Quality Control Strains

MAGNEX Injection (Sulbactam Sodium/Cefoperazone Sodium 1:1)

CIPLOX-D Eye Drops (Ciprofloxacin 0.3% + Dexamethasone 0.1%)

CEFPROZIL FOR ORAL SUSPENSION USP 125 mg/5 ml and 250 mg/5 ml. Rx Only

CEFPROZIL FOR ORAL SUSPENSION USP 125 mg/5 ml and 250 mg/5 ml. Rx only

Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents

Objective: To assess the incidence of healthcare-associated infections (HAI) and the prevalence

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

PHYSICIANS CIRCULAR. Tablets NOROXIN (norfloxacin, USP)

Treatment of febrile neutropenia in patients with neoplasia

HUSRES Annual Report 2009 Martti Vaara

Cefuroxime (as sodium)

Infection Data: Form Updates

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory AUGMENTIN DDS

Babak Valizadeh, DCLS

For use with Sofia only

Client Services M anual

DISEASE OUTBREAKS SUMMARY

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH

Transcription:

External Quality Assessment Scheme General Bacteriology 1 and 2. List of samples and the microbes linked to the corresponding photo replies since 1.1.2008 Microbe Survey/ Sample Specimen type. Patient data Photo number Aerobic Gram-Positive Cocci Staphylococci, Micrococci and related bacteria Staphylococcus aureus 2008-1/2 Skin smear. Eczema. DM. 5 Staphylococcus aureus 2008-3/9 Pus. Impetigo. 3 and 4 Staphylococcus aureus 2009-4/16 BAL sample. Neutropenic patient 17,19,20 and 21 Staphylococcus aureus 2010-3/9 Pus from skin pustule / Pemphi- 2,3 and 4 gus neonatorum Staphylococcus aureus 2010-3/10 Middle ear effusion 5,6,7 and 9 Staphylococcus aureus 2011-1/1 Pus from infected surginal wound 1,2,3 Staphylococcus aureus 2012-2/5 Pus. Skin eczema 6-9,12 Staphylococcus aureus 2014-4/42 Pus. Conjuctivitis in a child. 7-9 Staphylococcus epidermidis 2008-1/3 Tissue sample. TEP 9 Staphylococcus epidermidis 2008-2/8 Pus. Open leg fracture. 12 Staphylococcus epidermidis 2009-1/3 Tissue sample. Corneal ulcer 10 and 11 Staphylococcus epidermidis 2009-4/14 Conjuntival sample 6 and 7 Staphylococcus haemolyticum 2011-2/6 Smear sample behind earflap 6,7,8,9,10 Staphylococcus hominis 2010-4/14 Pus. Leg ulcer. 6,7 and 9 Staphylococcus hominis 2012-3/10 Pus- Leg ulcer 6-11,17 Staphylococcus hominis 2013-3/23 Pus from mandibular fistula 25 Staphylococcus intermedius 2013-4/31 Dog bite 3-8 Staphylococcus lugdunensis 2010-1/3 Cardiac pacemaker electrode 16,17,18,19 and 20 Staphylococcus lugdunensis 2013-2/12 Middle ear effusion 11-14 Staphylococcus lugdunensis 2014-3/31 Abscess on a toe 1-7 Staphylococcus warneri 2011-4/14 Middle ear effusion 5,6,7,12,13 Staphylococcus warneri 2012-4/16 Venous catheter 30-34 Staphylococcus warneri 2013-3/22 Contact lens infection 15-16 Staphylococcus xylosus 2012-4/16 Venous catheter 30-32,35-36. Coagulase negative staphylococcus. 2008-4/14 Pus. Impetigo. 7,8 and 9 Micrococcus sp. 2008-2/6 Middle ear effusion. 5 and 6 Micrococcus sp 2011-2/6 Smear sample behind earflap 6,7,8,9,11 Micrococcus sp 2013-2/12 Middle ear effusion 15 Streptococci, Enterococci and related bacteria 2008-4/14 Pus. Impetigo. 7,8 and 9 2009-2/5 Middle ear effusion. 3,4and 9 2010-1/2 Pus Axillary eczema 8,9,10,11 and 12 2012-1/1 Pus. Pharyngeal abscess 2,3,4,5 2014-1/12 Pus. Smear sample from skin. 10,11,12,13,14 and 17

Beta-hem.streptococcus group B 2010-4/14 Pus.Leg ulcer. 6,7 and 8 (Streptococcus agalactiae) Beta-hem.streptococcus group B 2012-2/8 Amnionic fluid 29-32,39-40 (Streptococcus agalactiae) Beta-hem.streptococcus group C (Streptococcus dysgalactiae ssp 2011-3/11 Pus. Abscess. 16,17,18,19,20 21,22 equisimilis) Beta-hem.streptococcus group F (Streptococcus anginosus) 2011-4/16 Pus. Pulmonal empyema 21,22,23,24,25 26 Beta-hem.streptococcus group G 2008-1/ 1 Pus. Peritonsillary abscess 3 Beta-hem.streptococcus group G 2009-2/6 Pus. Groin abscess. 6,7,8 and 9 Beta-hem.streptococcus group G 2012-3/10 Pus. Leg ulcer 5-13 Enterococcus faecalis Bile specimen 19-20, 23-24 Enterococcus faecium 2009-1/4 Pus. Groin abscess. 14,15,16 and 17 Enterococcus faecium 2013-4/33 Pus from pelvic abscess 29-31,35-36 Enterococcus casseliflavus 2011-2/7 Tip of venous catether 13,14,15,16,17 Leuconostoc sp. 2013-4/32 Leg ulcer 10-14,20-23 2008-2/5 Cerebrospinal fluid 3 2009-1/1 Pus. Maxillay sinusitis 3 2010-4/13 Cerebrospinal fluid. Meningitis 3 and 4 2011-4/14 Middle ear effusion 6,7,8,9,10,11 2012-3/9 Middle ear effusion 2,3,4 2013-2/12 Middle ear effusion 7-10 2014-1/41 Middle ear effusion 2-5 Streptococcus viridans 2009-2/7 Pus Abscess 14 and 15 Streptococcus viridans 2009-4/14 Conjuctival sample 6 and 7 Streptococcus viridans 2010-4/15 Pus. Frontal sinusitis. 10 and 28 Streptococcus viridans 2014-4/14 Middle ear effusion 6,7,8,9,11 Streptococcus viridans 2014-3/32 Maxillary sinus excretion 8-12,16 Streptococcus viridans 2014-3/34 Pleural empyema 28-31,33-41 Streptococcus anginosus 2008-4/15 Aortic valve. Endocarditis. 11-12 Streptococcus anginosus 2011-4/16 Pus. Pulmonal empyema 21,22,23,24,25 26 Streptococcus parasanguis 2009-3/11 Cardiac valve. Endocarditis 15,16 and 17 Aerobic Gram-Positive Bacilli Actinomadura madurae 2012-1/3 Tissue specimen. Leg ulcer. 15-25 Arcanobacterium haemolyticum 2011-1/2 Purulent maxillary sinus excretion 5,6,7,8,9,10,11 Arcanobacterium haemolyticum 2014-3/32 Maxillary sinus excretion 8-15 Bacillus cereus 2009-1/3 Tissue sample. Corneal ulcer 10,11 and 12 Bacillus cereus 2011-2/6 Smear sample behind earflap 6,7,8,9,12 Bacillus megaterium 2014-1/12 Pus, Smear sample from skin 10-16,21 Corynebacterium sp.(diphtheroid) 2008-1/2 Skin smear. Eczema. DM. 5 and 7 Corynebacterium sp.(diphtheroid) 2008-2/6 Middle ear effusion 5 and 6 Corynebacterium jeikeum 2011-3/10 Pus. Leg burn 7,8,9,10,14,15 Corynebacterium jeikeum 2013-2/13 Tissue specimen 16-21 Corynebacterium ulcerans 2012-3/11 Troat specimens 18-25 Corynebacterium urealyticum 2010-2/7 Pus. Obstructed urether 12,13,14,15 and 16 Dermabacter hominis 2013-3/24 Smear sample from nipple 27-32 spearcing Listeria monocytogenes 2010-4/16 Amnionic fluid 30,31,32,33,34 35

Listeria monocytogenes 2014-1/11 Smear sample from placenta 3,4,5,6,7,8 Rhodococcus equi 2010-3/12 Sputum sample/ An immunocompromized patient 25,26,27,28 and 29 Aerobic Gram-Negativive Cocci Moraxella catarrhalis 2008-2/6 Middle ear effusion 5 and 6 Moraxella catarrhalis 2009-3/9 Middle ear effusion 3 and 4 Moraxella catarrhalis 2010-3/10 Middle ear effusion 5,6,7 and 9 Moraxella catarrhalis 2012-4/14 Middle ear effusion 6-12 Neisseria gonorrhoeae 2008-4/13 Synovial fluid 3,4 and 5 Neisseria gonorrhoeae 2011-2/8 Pus from infected big toe 18,19,20,21,22 Neisseria gonorrhoeae 2013-1/1 Pus from uterine cavity 3,4,5,6 Neisseria menigitidis 2012-1/2 Pus. Maxillary sinusitis 6-8,12-13 Neiseria mucosa 2011-1/2 Purulent maxillary sinus excretion 5,6,7,14,15 Neisseria sicca 2014-3/32 Maxillary sinus excretion 8-12,17-18 Aerobic Gram-Negative Bacilli Fermentative rods Acinetobacter baumannii 2008-4/16 Cerebrospinal fluid. 14,15,16 and 17 Acinetobacter baumannii 2009-4/14 Conjunctival sample. 6,7,8,9 and 10 Aeromonas hydrophila 2008-2/8 Pus. Open leg fractura. 12 Citrobactrer koseri (C diversus) 2012-3/12 Ascites fluid 28-34 Citrobacter werkmanii 2014-4/44 Pus from gall bladder 29-32,33-34,37 Cronobacter sakazakii See Enterobacter sakazakii Enterobacter aerogenes 2013-1/3 Bile specimen 19-22 Enterobacter cloacae 2008-4/16 Cerebrospinal fluid. 14,15,16 and 17 Enterobacter cloacae 2009-4/16 Bal sample. Neutropenic patient 17,22 and 23 Enterobacter cloacae 2014-1/14 Tissue. Leg ulcer. 36-42 Enterobacter (Cronobacter) sakazaii 2011-1/3 Ascites fluid. Traffic accident. 16,17,18,19,20 21,27,28,31,37 Escherichia coli 2008-3/12 Ascites fluid 14 Escherichia coli 2009-2/8 Ascites fluid 20 and 21 Escherichia coli 2011-1/3 Ascites fluid. Traffic accident. 16,17,18,19,20 21,24,25,26,31 Escherichia coli 2012-2/6 Pus. Skin eczema 6-9,13-15 Escherichia coli, CPE 2013-2/11 Wound 3-5 Hafnia alvei 2014-1/14 Tissue. Leg ulcer. 36-39,43-45 Klebsiella oxytoca 2012-4/15 Pus from snake bite 13-19 Klebsiella pneumoniae 2010-1/1 Pus. Leg fractura. 3,4,5 and 6 Klebsiella pneumoniae 2010-3/11 Pus. Ovarial abscess 11,12,13,14,15 16,18 and 19 Klebsiella pneumoniae 2011-2/5 Pus from pancreatic drainage 2,3,4,5 Klebsiella pneumoniae ssp rhinoscleromtis 2013-1/2 Maxillary sinus excretion 7-13 Ochrobactrum anthropi 2011-3/11 Pus. Abscess. 16,17,18,19,20 24,25,26,27 Morganella morgnii 2013-4/33 Pus frompelvic abscess 29-34 Proteus mirabilis 2009-1/2 External ear canal effusion 5,6 and 7 Proteus vulgaris 2010-2/8 Pus. Cholecystitis. 18,19,20,22,23 and 26 Proteus vulgaris 2012-4/15 Pus from snake bite 13-17, 20-21 Rahnella aquatilis 2014-4/43 Pus. Wound. Fish farming 13-19,23-25. Salmonella sp 2011-1/3 Ascites fluid. Traffic accident. 16-21,24,29-31 Salmonella sp. (S Enteritidis) 2014-4/44 Pus from gall bladder 29-32,35-37. Serratia fonticola 2008-3/12 Ascites fluid 14 Serratia fonticola 2013-4/32 Leg ulcer 10-19 Serratia rubidaea 2010-2/8 Pus. Cholecystitis. 18,19,20,24,25 and 25

Nonfermentative rods Achromobacter denitrificans 2009-2/6 Skin eruption. Groin. 6,7,9,10 11 and 12 Achromobacter xylosoxidans 2013-3/22 Contact lens infection 8-14 Chryseomonas meningoseptica. Kts. Elizabethkingia meningoseptica Elizabethkingia meningoseptica 2009-3/10 Pus. Maxillary sinusitis. 6,7,8,10,11,12 13 and 23 Pasteurella multocida 2011-1/4 Tissue sample. Dog bite. 33,34,35,36 Pasteurella multocida 2011-4/13 Tissue sample. Animal bite. 2,3,4,5 Pasteurella multocida 2014-1/13 Pus from cheek abscess. Cat bite. 23,24,25,26 Pseudomonas aeruginosa 2008-2/7 Ascites fluid. 8 Pseudomonas aeruginosa 2009-4/13 Sputum. Cystic fibrosis 3 and 4 Pseudomonas aeruginosa 2011-3/9 External ear canal exudate 2,3,4,5 and 6 Pseudomonas aeruginosa 2012-3/10 Pus. Leg ulcer 6-11,13-16 Pseudomonas oryzihabitans 2013-1/2 Pus, Maxillary sinus excretion. 8-10,14-16 Pseudomonas stutzeri 2014-1/12 Pus. Smear sample from skin 10-16, 18-20 Ralstonia pickettii 2010-2/6 Aqua destillata 6,7,8,9 and 10 Sphingobacterium multiforum 2009-3/12 Skin wound. 19,20,21,22 and 23 Stenotrophomonas maltophilia 2008-2/8 Pus. Open leg fractura. 12 Stenotrophomonas maltophilia 2011-3/10 Pus. Leg burn 7-13 Vibrio parahaemolyticus 2014-4/43 Pus. Wound. Fish farming, 13-22 Haemophilus strains Haemophilus influenzae 2009-3/10 Pus. Maxillary sinusitis 9 Haemophilus influenzae 2010-2/5 Pus. Maxillary sinusitis 3 and 4 Haemophilus influenzae 2010-3/10 Middle ear effusion 5,6,7 and 8 Haemophilus influenzae 2012-1/2 Pus. Maxillary sinusitis 6-11 Haemophilus influenzae 2012-2/5 Pus. Maxillary sinusitis 2-5 Haemophilus influenzae 2012-4/13 Middle ear effusion 2-5 Haemophilus influenzae 2013-3/21 Pus. Maxillary sinusitis 3-6 Haemophilus parainfluenzae 2011-1/2 Purulent maxillary sinus excretion 5,6,7,12,13 Haemophilus parainfluenzae 2014-2/42 Pus. Conjunctivitis in a child 7-12 Other Gram-Negative Bacilli and Vibrios Actinobacillus actinomycetemcomitans kts. Aggregatibacter actinom. Aggregatibacter actinomycetemcomitans 2009-2/7 Pus Abscess 14,15,16,17 and 18 Capnocytophaga canimorsus 2013-1/4 Wound. Dog bite. 35-39 Cardiobacterium hominis 2014-3/33 A piece of cardiac valve 19-25 Eikenella corrodens 2013-3/23 Pus from mandibular fistula 18-24 Vibrio vulnificus 2008-3/10 Skin wound. Sushi bar keeper. 6,7 and 8 Anaerobic Gram-Positive Cocci Finegoldia magna 2011-4/16 Pus. Pulmonal empyema. 21,27,28,29,30 31,32,33,34,39 40,41,42 Finegoldia magna 2012-1/4 Pus. Brain abscess 26,31-34,41-44 Peptostreptococcus anaerobius 2009-1/4 Pus. Groin abscess. 17,18,19,22,23 and 24 Peptostreptococcus anaerobius 2012-2/8 Amnionic fluid 29-30,31-37,41-44 Staphylococcus saccharolyticus 2013-2/14 Tissue specimen lumbar vertebra 29-36 Anaerobic Gram-Positive Bacilli Actinomyces israelii 2010-3/11 Pus. Ovarial abscess 11-17, 20-24 Actinomyces mayeri 2014-3/34 Pleural empyema 29-32 Actinomyces naeslundi 2008-1/4 Pus. Brain abscess. 11,12 and 13 Actinomyces odontolyticus 2012-1/4 Pus. Brain abscess 26,34,38-41 Clostridium innocuum 2010-1/4 Pus. Liver abscess. 22,23,24,25,26 and 27

Clostridium innocuum 2013-2/13 Tissue specimen 22-28 Clostridium ramosum 2014-4/44 Pus from gall bladder 38-47. Clostridium septicum 2012-4/15 Pus from snake bite 22-29 Clostridium perfringens 2013-4/33 Pus from pelvic abscess 37-42 Clostridium sporogenes 2009-2/8 Ascites fluid. 21,22,23,25,26 28 and 29 Clostridium sporogenes 2012-3/12 Ascites fluid 28-29,44-46 Clostridium tertium 2012-2/7 Myonecrosis. Tissue specimen 18-28 Eggerthella lenta 2012-2/8 Amnionic fluid 29-30,33-37,45-48 Propionibacter acnes 2009-4/15 Skin smear sample around a cystofix catheter 12,13,14 and 15 Propionibacter acnes 2011-2/8 Pus from infected big toe 18,23,24,25,26 Propionibacter acnes 2013-3/24 Smear sample from nipple 33-36 spearcing Anaerobic Gram-Negative Bacilli Bacteroides fragilis 2008-2/7 Ascites fluid 9 Bacteroides fragilis 2009-1/4 Pus. Groin abscess 17,18,19,20,21 23 and 24 Bacteroides fragilis 2010-2/8 Pus. Cholecystitis. 21,27,28 and 29 Bacteroides fragilis 2014-1/14 Tissue specimen. Leg ulcer. 46-52 Bacteroides ovatus 2012-3/12 Ascites fluid 28-29,35-43 Bacteroides thetaiotamicron 2008-3/12 Ascites fluid 15 and 16 Bacteroides vulgatus 2011-3/11 Pus. Abscess. 16,28,29,30,31 32 Bacteroides vulgatus 2013-1/3 Bile specimen 19-20, 25-34 Fusobacterium necrophorum 2010-4/15 Pus. Frontal sinusitis. 12,13,14,16 18,19,20,21,22 Fusobacterium nucleatum 2011-4/16 Pus. Pulmonal empyema. 21,27,28,29,30 31,32,33,34 35,36,37,38 Fusobacterium nucleatum 2013-4/34 Pus taken by bronchoscopy 44-48,53-55 Fusobacterium russii 2014-1/13 Pus from cheek abscess. Cat bite. 27-34 Prevotella disiens 2009-2/8 Ascites fluid 21,22,24,25,27 28 and 29 Prevotella melanogenica 2008-1/4 Pus. Brain abscess. 11,12 and 13 Prevotella melanogenica 2010-4/15 Pus. Frontal sinusitis. 12,13,14,15,23 24,25,26,27 Prevotella melanogenica 2013-4/34 Pus taken by bronchoscopy. 44-52 Mycobacteria Mycobacterium abscessus 2008-3/11 Tissue sample. Corneal ulcer. 10 and 11 Mycobacterium abscessus 2011-4/15 Tissue sample. Arm ulcer. 13,14,15,16,17 18,19,20 Yeasts and Molds Candida albicans 2008-1/2 Skin smear. Eczema. DM. 5,6,7 Candida albicans 2008-2/7 Ascites fluid 10 Candida albicans 2010-1/2 Pus Axillary eczema 8,9,10,13 and 14 Candida albicans 2012-2/6 Pus. Skin eczema 6-10,16-17 Candida glabrata 2009-4/16 Bal sample. Neutropenic patient 17,18,24 and 25 Candida glabrata 2013-4/32 Leg ulcer 10-14,24-26 Aspergillus fumigatus 2009-1/2 External ear canal effusion 5 and 8 Information Yvonne Björkman +358 9 8566 8222 yvonne.bjorkman@labquality.fi

Labquality Ratamestarinkatu 11 FI-00520 Helsinki FINLAND Telephone +358 9 8566 8200 Fax +358 9 8566 8280 +358 9 8566 8281 info@labquality.fi www.labquality.fi Labquality